// App-Quantinova.ai

TCT-51 : In hospital and one month outcomes of 983 patients implanted with bioresorbable vascular scaffolds for Acute Coronary Syndroms ; subgroup of the prospective, all comers, controlled, multicenter, FRANCE ABSORB Registry.

Researchers

Presenter

  • Joel Sainsous

Principal Investigators

  • Jean Fajadet

  • Didier Carrie

  • Simon Elhadad

  • Rene Koning

  • Herve Le Breton

Medical Centers

  • Hopital Rangueil, Toulouse, France

  • Clinique Pasteur, Toulouse, France

  • Clinique Saint Hilaire, Rouen, France

  • Clinique Rhone Durance, Avignon, France

  • CHU Pontchaillou, Rennes, France

  • CH Marne La Vallee, Saint Maur, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Cardiovascular (CVS)

Disease

  • Angina

  • Venous thrombosis

  • Diabetes

  • Generalized arterial calcification of infancy

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Heparin

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved